<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
  <head>
    <meta content="text/html; charset=windows-1252"
      http-equiv="Content-Type">
    <title>Andrei Gudkov -- Flagellin vs Radiation</title>
  </head>
  <body>
    <div style="margin-left: 40px;"><img style="width: 124px; height:
        82px;" alt="" src="0logo.gif"><br>
      <b><font face="Papyrus"><font color="#000000"><font size="+1"><a
                href="../index.htm">rexresearch.com</a></font></font></font></b></div>
    <div style="margin-left: 40px;"> </div>
    <span style="font-weight: bold;"></span>
    <hr style="width: 62%; height: 2px;"><br>
    <div style="text-align: center;"><big><big><span style="font-weight:
            bold;">Andrei GUDKOV</span><br style="font-weight: bold;">
        </big></big></div>
    <div style="text-align: center; margin-left: 40px;"><big><big><br
            style="font-weight: bold;">
          <span style="font-weight: bold;">Flagellin vs Radiation<br>
            <br>
          </span></big></big>
      <hr style="width: 62%; height: 2px;"><br>
      <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
      <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
      <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
      <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
      <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
      <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
      <hr size="2" width="100%"><br>
      <div style="margin-left: 40px;">
        <div align="left"><a
href="http://www.theaustralian.news.com.au/story/0%2C25197%2C25797329-15084%2C00.html"
            "><span style="font-weight: bold;">http://www.theaustralian.news.com.au/story/0%2C25197%2C25797329-15084%2C00.html</span><span
              style="font-weight: bold;"></span></a><br>
        </div>
        <div align="left"><span style="font-weight: bold;"><span
              style="font-style: italic;">The Australian</span> ( July
            18, 2009 )</span><br>
        </div>
      </div>
      <br>
      <div style="text-align: center; margin-left: 40px;"><big><span
            style="font-weight: bold;">New Drug Shields Against
            Radiation</span><br style="font-weight: bold;">
          <br style="font-weight: bold;">
          <span style="font-weight: bold;">by</span><br
            style="font-weight: bold;">
          <br style="font-weight: bold;">
          <span style="font-weight: bold;">Rabinovich</span><br
            style="font-weight: bold;">
        </big></div>
      <div style="margin-left: 40px;"><br>
        <div align="left"> A medication that can protect people exposed
          to normally lethal doses of radiation from a nuclear or a
          "dirty" bomb has been developed, reports say.<br>
          <br>
          In tests involving 650 monkeys exposed to radiation equivalent
          to that recorded during the Chernobyl nuclear reactor disaster
          in 1986, 70 per cent died while the rest suffered serious
          maladies, the newspaper <span style="font-style: italic;">Yediot




            Achronot</span> said yesterday.<br>
          <br>
          Of the group given anti-radiation shots, almost all survived
          and had no side effects. A test on humans not exposed to
          radiation showed none suffered side effects from the
          medication.<br>
          <br>
          The medication was developed by Andrei Gudkov, chief
          scientific officer at Cleveland BioLabs in the US. Also
          involved was Israel's Elena Feinstein.<br>
          <br>
          "We made a breakthrough that may save the lives of millions,"
          Dr Gudkov was quoted as saying.<br>
          <br>
          The medication has important implications in the treatment of
          cancer, the report said, since it permits use of more powerful
          radiation.<br>
          <br>
          If the medication is given final approval by the Food and Drug
          Administration, which Dr Gudkov said would happen within two
          years, it could have a strategic impact, particularly for
          nations threatened with nuclear attack. Among the major fears
          in the West is not nuclear attack but "dirty bombs", which
          kill mostly by radiation.<br>
          <br>
          Dr Gudkov conceived the idea in 2003 of using protein produced
          in bacteria found in the intestine to protect cells from
          radiation. "The medication works by suppressing the 'suicide
          mechanism' of cells hit by radiation," the newspaper said,
          "while enabling them to recover from the radiation-induced
          damages that prompted them to activate the suicide mechanism
          in the first place."<br>
          <br>
          The medication is a preventative drug administered by one or
          several doses.<br>
          <br>
        </div>
        <hr style="width: 62%; height: 2px;" align="left">
        <div align="left"><br>
          <a href="http://en.wikipedia.org/wiki/Flagellin"
            "><span style="font-weight: bold;">http://en.wikipedia.org/wiki/Flagellin</span></a><br>
          <span style="font-weight: bold;"> </span><br>
          <span style="font-weight: bold;"> </span></div>
        <div style="text-align: center;" align="left"><big><span
              style="font-weight: bold;">Flagellin</span></big><br
            style="font-weight: bold;">
        </div>
        <div align="left"><br>
          Flagellin is a protein that arranges itself in a hollow
          cylinder to form the filament in bacterial flagellum. It has a
          mass of about 30,000 to 60,000 daltons. Flagellin is the
          principal substituent of bacterial flagellum, and is present
          in large amounts on nearly all flagellated bacteria.<br>
          &nbsp;<br>
          <span style="font-weight: bold;">Structure</span><br
            style="font-weight: bold;">
          <br>
          The structure of flagellin is responsible for the helical
          shape of the flagellar filament, which is important for its
          proper function.<br>
          <br>
          The N- and C-termini of flagellin form the inner core of the
          flagellin protein, and is responsible for flagellin's ability
          to polymerize into a filament. The central portion of the
          protein makes up the outer surface of the flagellar filament.
          While the termini of the protein is quite similar between all
          bacterial flagellins, the central portion is wildly variable.<br>
          <br>
          <span style="font-weight: bold;">Immune response</span><br
            style="font-weight: bold;">
          <br style="font-weight: bold;">
          <span style="font-weight: bold;">In mammals</span><br
            style="font-weight: bold;">
          <br>
          Mammals often have acquired immune responses (T-cell and
          antibody responses) to flagellated bacterium occurs frequently
          to flagellar antigens. Some bacteria are able to switch
          between multiple flagellin genes in order to evade this
          response.<br>
          <br>
          The propensity of the immune response to flagellin may be
          explained by two facts:<br>
          <br>
          First, flagellin is an extremely abundant protein in
          flagellated bacteria.<br>
          Secondly, there exists a specific innate immune receptor that
          recognizes flagellin, Toll-like receptor 5 (TLR5).<br>
          <br>
          <span style="font-weight: bold;">In plants</span><br
            style="font-weight: bold;">
          <br>
          In addition a 22 amino acid sequence (flg22) of the conserved
          N-terminal part of flagellin is known to activate plant
          defence mechanisms. Flagellin perception in Arabidopsis
          thaliana functions via the receptor-like-kinase, FLS2
          (flagellin-sensitive-2)). Mitogen-activated-protein-kinases
          (MAPK) acts as signalling compounds and more than 900 genes
          are affected upon flg22 treatment.<br>
          <br>
          Pre-stimulation with a synthetic flg22-peptide led to enhanced
          resistance against bacterial invaders.<br>
          <br>
        </div>
        <hr style="width: 62%; height: 2px;" align="left">
        <div align="left"><br>
          <a
href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&amp;term=Flagellin%5C"
            "><span style="font-weight: bold;">http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&amp;term=Flagellin\</span></a><br
            style="font-weight: bold;">
          <br>
          MeSH Heading --&nbsp; Flagellin<br>
          Tree Number&nbsp; --&nbsp; D12.776.097.380<br>
          Annotation&nbsp; -&nbsp; a bact protein<br>
          Scope Note -- &nbsp; A protein with a molecular weight of
          40,000 isolated from bacterial flagella. At appropriate pH and
          salt concentration, three flagellin monomers can spontaneously
          reaggregate to form structures which appear identical to
          intact flagella.<br>
          <br>
        </div>
      </div>
      <hr style="width: 62%; height: 2px;" align="left">
      <div style="text-align: center;">
        <div align="left"><br>
          <a href="http://www.ncbi.nlm.nih.gov/pubmed/11489966"
            "><span style="font-weight: bold;">http://www.ncbi.nlm.nih.gov/pubmed/11489966</span></a><br
            style="font-weight: bold;">
          <span style="font-weight: bold;">J Immunol. 2001 Aug
            15;167(4):1882-5</span><br style="font-weight: bold;">
          <br style="font-weight: bold;">
        </div>
        <div style="text-align: center;" align="left"><big><span
              style="font-weight: bold;">Bacterial flagellin activates
              basolaterally expressed TLR5 to induce epithelial
              proinflammatory gene expression.</span><br
              style="font-weight: bold;">
            <br style="font-weight: bold;">
            <span style="font-weight: bold;">Gewirtz AT, Navas TA, Lyons
              S, Godowski PJ, Madara JL.</span></big><br
            style="font-weight: bold;">
        </div>
        <div align="left"><br>
          Epithelial Pathobiology Division, Department of Pathology and
          Laboratory Medicine, Emory University, Atlanta, GA 30322, USA
          ski@gene.com.<br>
          <br>
          Flagellin, the structural component of bacterial flagella, is
          secreted by pathogenic and commensal bacteria. Flagellin
          activates proinflammatory gene expression in intestinal
          epithelia. However, only flagellin that contacts basolateral
          epithelial surfaces is proinflammatory; apical flagellin has
          no effect. Pathogenic Salmonella, but not commensal
          Escherichia coli, translocate flagellin across epithelia, thus
          activating epithelial proinflammatory gene expression.
          Investigating how epithelia detect flagellin revealed that
          cell surface expression of Toll-like receptor 5 (TLR5)
          conferred NF-kappaB gene expression in response to flagellin.
          The response depended on both extracellular leucine-rich
          repeats and intracellular Toll/IL-1R homology region of TLR5
          as well as the adaptor protein MyD88. Furthermore,
          immunolocalization and cell surface-selective biotinylation
          revealed that TLR5 is expressed exclusively on the basolateral
          surface of intestinal epithelia, thus providing a molecular
          basis for the polarity of this innate immune response. Thus,
          detection of flagellin by basolateral TLR5 mediates
          epithelial-driven inflammatory responses to Salmonella.<br>
          <br>
        </div>
        <hr style="width: 62%; height: 2px;" align="left">
        <div align="left"><br style="font-weight: bold;">
        </div>
        <div style="text-align: center;" align="left"><span
            style="font-weight: bold;">WO2005056042</span><br
            style="font-weight: bold;">
          <span style="font-weight: bold;">METHODS OF PROTECTING AGAINST
            RADIATION USING FLAGELLIN</span><br style="font-weight:
            bold;">
        </div>
        <div align="left"><br>
          <span style="font-weight: bold;">Abstract</span> --The
          invention relates to a method of protecting a mammal against
          radiation comprising administering said mammal a composition
          containing flagellin.<br>
          <br>
          Also published as: &nbsp;&nbsp; WO2005056042 // WO2005056055
          // WO2005056055 // WO2005057218<br>
        </div>
        <br>
        <hr size="2" width="100%"><br>
        <big><span style="font-family: Comic Sans MS; font-weight:
            bold;"><span style="color: rgb(204, 0, 0);"></span></span></big></div>
      <big><span style="font-family: Comic Sans MS; font-weight: bold;"><span
            style="color: rgb(204, 0, 0);"> <br>
          </span></span></big>
      <hr style="width: 62%; height: 2px;">
      <div align="center"><img alt="" src="0logo.gif" height="82"
          width="124"><br>
        <br>
      </div>
      <div style="text-align: center;"><b>Your Support Maintains this
          Service -- </b><b><br>
        </b> <b><br>
        </b> <b>BUY</b><b><br>
        </b> <b><br>
        </b> <big><b>The</b><b> Rex Research Civilization Kit </b></big><b><br>
        </b> <b><br>
        </b> <b>... It's Your Best Bet &amp; Investment in
          Sustainable Humanity on Earth ... </b><b><br>
        </b><b> Ensure &amp; Enhance Your Survival &amp; Genome
          Transmission ...</b><b> </b><b><br>
        </b> <b>Everything @ rexresearch.com on a Data DVD ! </b><b><br>
        </b> <b><br>
        </b> <b><a href="order.htm"
            ">ORDER PAGE</a></b><b><br>
        </b> <b><br>
        </b> <big><b>Rex Research, POB 19250, Jean, NV 89019 USA</b></big><b><br>
        </b> </div>
      <b> </b><b><br>
      </b><b> </b>
      <hr style="width: 62%; height: 2px;">
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script>
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script></div>
  </body>
</html>
